Company news
Yabao Pharmaceutical Group Co. Ltd. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Announcement on Obtaining Commitment Letter for Share Repurchase Loans from Financial Institutions
June 23, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
May 29, 2025
Announcement on Implementation of Dividend Distribution for 2024
May 23, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 16, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Shanxi Jurisdiction
May 14, 2025
Announcement on Shareholding of Top 10 Shareholders Concerning Shares Repurchase
May 12, 2025
2024 Annual Report
April 25, 2025
Announcement on Release of Pledge of Some Shares of Controlling Shareholder
April 18, 2025
Announcement on Implementation Results of Share Repurchase and Share Changes
March 3, 2025
Announcement on ZY-A001 Obtaining Notice of Approval for Drug Clinical Trials
February 14, 2025
Announcement on the Repurchased Company Shares Reaching 1% and Repurchase Progress
February 5, 2025
Announcement on the Termination of the Technology Transfer Agreement for the Traditional Chinese Medicine New Drug Project
January 17, 2025
Announcement on a Wholly-owned Subsidiary Obtaining One Drug Registration Certificate
November 21, 2024
Announcement on Convening the Q3 2024 Performance Briefing
November 4, 2024
Announcement on Correction of Report for Q3 2024
October 25, 2024
Report for Q3 2024
October 24, 2024
Announcement on Obtaining Approval of Phase II Clinical Trial for New Indication of Project SY-009
September 29, 2024
Announcement on Notice to Creditors
September 3, 2024
Announcement on Convening 2024 Semi-annual Performance Briefing
August 16, 2024
Announcement on Resolutions of the 6th Meeting of the 9th Board of Directors
August 14, 2024